Sjögren’s takes center stage at the American College of Rheumatology’s Convergence 2025 conference. The Sjögren’s Foundation joined researchers, clinicians, and advocates in Chicago for this major meeting. With extensive sessions, new promising clinical trial data, and unprecedented visibility for Sjögren’s disease, this year’s event reflected major progress in research and recognition. Read a recap of this year’s event and what it means for the future of Sjögren’s disease.
Sjögren’s takes center stage at the American College of Rheumatology’s Convergence 2025 conference. The Sjögren’s Foundation joined researchers, clinicians, and advocates in Chicago for this major meeting. With extensive sessions, new promising clinical trial data, and unprecedented visibility for Sjögren’s disease, this year’s event reflected major progress in research and recognition. Read a recap of this year’s event and what it means for the future of Sjögren’s disease.